Ken Griffin Options Holdings

Citadel Advisors LLC

  • $509 Billion
  • Q1 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
XERS
Xeris Biopharma Holdings, Inc.

Healthcare
PUT
$306,000
55.8K
Q1 2025
Added 157.14%
XRX
Xerox Holdings Corp

Technology
CALL
$1.13 Million
234K
Q1 2025
Reduced 86.8%
XRX
Xerox Holdings Corp

Technology
PUT
$1.56 Million
323K
Q1 2025
Reduced 86.8%
XOMA
Xoma Corp

Healthcare
CALL
$3,000
200
Q1 2025
Reduced 77.27%
XOMA
Xoma Corp

Healthcare
PUT
$9,000
500
Q1 2025
Reduced 77.27%
XMTR
Xometry, Inc.

Industrials
CALL
$812,000
32.6K
Q1 2025
Added 12.08%
XMTR
Xometry, Inc.

Industrials
PUT
$832,000
33.4K
Q1 2025
Added 12.08%
XP
Xp Inc.

Financial Services
CALL
$1.85 Million
135K
Q1 2025
Added 14.04%
XP
Xp Inc.

Financial Services
PUT
$9.06 Million
659K
Q1 2025
Added 14.04%
YALA
Yalla Group LTD

Technology
CALL
$25,000
4.9K
Q1 2025
Reduced 47.84%
MGK
Vanguard Mega Cap Growth ETF

ETFs
CALL
$4.17 Million
13.5K
Q1 2025
Reduced 4.48%
VTR
Ventas, Inc.

Real Estate
PUT
$7.16 Million
104K
Q1 2025
Added 2.96%
Venture Global Inc
CALL
$0
509K
Q1 2025
New holding
Venture Global Inc
PUT
$0
261K
Q1 2025
New holding
VTYX
Ventyx Biosciences, Inc.

Healthcare
CALL
$18,000
16.2K
Q1 2025
Reduced 63.91%
VTYX
Ventyx Biosciences, Inc.

Healthcare
PUT
$24,000
21.4K
Q1 2025
Reduced 63.91%
Veon LTD
CALL
$0
800
Q1 2025
Reduced 12.86%
Veon LTD
PUT
$0
27.1K
Q1 2025
Reduced 12.86%
VERA
Vera Therapeutics, Inc.

Healthcare
CALL
$552,000
23K
Q1 2025
Reduced 69.7%
VERA
Vera Therapeutics, Inc.

Healthcare
PUT
$216,000
9K
Q1 2025
Reduced 69.7%
VCYT
Veracyte, Inc.

Healthcare
CALL
$59,000
2K
Q1 2025
Added 283.33%
VCYT
Veracyte, Inc.

Healthcare
PUT
$68,000
2.3K
Q1 2025
Added 283.33%
Veralto Corp
CALL
$0
22K
Q1 2025
Reduced 94.64%
Veralto Corp
PUT
$0
4.28K
Q1 2025
Reduced 94.64%
Verastem Inc
CALL
$0
13.7K
Q1 2025
Reduced 31.19%
VTR
Ventas, Inc.

Real Estate
CALL
$4.55 Million
66.2K
Q1 2025
Added 2.96%
VEL
Velocity Financial, Inc.

Financial Services
PUT
$2.31 Million
123K
Q1 2025
Reduced 21.56%
MGK
Vanguard Mega Cap Growth ETF

ETFs
PUT
$1.98 Million
6.4K
Q1 2025
Reduced 4.48%
MGV
Vanguard Mega Cap Value

ETFs
CALL
$25,000
200
Q1 2025
Added 150.0%
MGV
Vanguard Mega Cap Value

ETFs
PUT
$64,000
500
Q1 2025
Added 150.0%
VREX
Varex Imaging Corp

Healthcare
CALL
$97,000
8.4K
Q1 2025
Added 122.22%
VREX
Varex Imaging Corp

Healthcare
PUT
$46,000
4K
Q1 2025
Added 122.22%
VRNS
Varonis Systems Inc

Technology
CALL
$1.32 Million
32.6K
Q1 2025
Reduced 48.56%
VRNS
Varonis Systems Inc

Technology
PUT
$1.38 Million
34K
Q1 2025
Reduced 48.56%
VXRT
Vaxart, Inc.

Healthcare
CALL
$5,000
14.3K
Q1 2025
Reduced 24.78%
VXRT
Vaxart, Inc.

Healthcare
PUT
$13,000
34K
Q1 2025
Reduced 24.78%
PCVX
Vaxcyte, Inc.

Healthcare
CALL
$1.91 Million
50.5K
Q1 2025
Reduced 31.32%
PCVX
Vaxcyte, Inc.

Healthcare
PUT
$687,000
18.2K
Q1 2025
Reduced 31.32%
VECO
Veeco Instruments Inc

Technology
CALL
$620,000
30.9K
Q1 2025
Added 59.92%
VECO
Veeco Instruments Inc

Technology
PUT
$1.59 Million
79K
Q1 2025
Added 59.92%
VEL
Velocity Financial, Inc.

Financial Services
CALL
$437,000
23.4K
Q1 2025
Reduced 21.56%
Verastem Inc
PUT
$0
20.3K
Q1 2025
Reduced 31.19%
Veren Inc
CALL
$0
15.2K
Q1 2025
Added 126.55%
Veren Inc
PUT
$0
62.3K
Q1 2025
Added 126.55%
VRNA
Verona Pharma PLC

Healthcare
CALL
$5.92 Million
93.2K
Q1 2025
Added 88.24%
VRNA
Verona Pharma PLC

Healthcare
PUT
$15.1 Million
239K
Q1 2025
Added 88.24%
VRRM
Verra Mobility Corp

Industrials
CALL
$864,000
38.4K
Q1 2025
Added 876.92%
VRRM
Verra Mobility Corp

Industrials
PUT
$571,000
25.4K
Q1 2025
Added 876.92%
VBNK
Versa Bank

Financial Services
CALL
$2,000
200
Q1 2025
New holding
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 17,161
  • Current Value $509 Billion
  • Prior Value $559 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1,248 stocks
  • Additional Purchases 2,438 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,161 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email